Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. [electronic resource]
Producer: 20100617Description: 1600-7 p. digitalISSN:- 1532-1827
- Adenocarcinoma -- diagnosis
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Pharmacological -- analysis
- Biomarkers, Tumor -- metabolism
- Cell Nucleus -- metabolism
- Cell Proliferation
- DNA-Binding Proteins -- metabolism
- Endonucleases -- metabolism
- Esophageal Neoplasms -- diagnosis
- Female
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Platinum Compounds -- administration & dosage
- Prognosis
- Stomach Neoplasms -- diagnosis
- Survival Analysis
- Tissue Array Analysis
- Treatment Outcome
- Tumor Burden -- physiology
No physical items for this record
Publication Type: Evaluation Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.